Researchers will develop a rapid bedside test to quickly assess the severity of central nervous system injury in dogs.

Researchers will evaluate commercially available medications for dogs with fungal diseases.

Researchers will conduct a clinical trial to evaluate a novel therapy for recurrent and multi-drug resistant urinary tract infections in dogs.

Researchers will develop innovative tools to study dilated cardiomyopathy, a common cause of heart failure, in Doberman pinschers, a high at-risk breed.

Researchers will evaluate a novel imaging method to help diagnose the spread of cancer to lymph nodes in malignant head and neck tumors in dogs.

Researchers will evaluate the potential of a novel drug derived from the feverfew plant to treat rapidly fatal canine cancers.

Researchers will compare the effects of three general anesthetic agents to find better anesthetic options for patients with intracranial disease.

Researchers will conduct a clinical trial investigating the safety and anticancer effectiveness of trametinib, a drug to treat companion dogs with aggressive cancers.

Researchers will evaluate the safety and efficacy of the drug clevidipine in dogs with congestive heart failure associated with mitral valve disease.